Evoq Remedies reschedules its board meeting from May 14 to May 27, 2026, to discuss audited financial results.
The meeting will consider audited financial results for the half-year and year ended March 31, 2026.
Disclosure is made pursuant to SEBI Listing Regulations Regulation 29(1) requirements.